BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  XVIVO Presents Interim Report January-June 2023

  Net sales amounted to SEK 154.6 million, corresponding to an increase of 64 percent in SEK and 52 percent in local currencies.

  July 13, 2023

   · 

  5 min read
• Business

  HUTCHMED Announces Changes to Board of Directors and Technical Committee Ms Ling Yang to replace Mr Lefei Sun as Non-executive Director; Professor Solange Peters appointed as Special Advisor to the Technical Committee

  HUTCHMED Limited announces that with effect from July 13, 2023:

  July 13, 2023

   · 

  6 min read
• Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting

  Opthea Limited announced that OPT-302, the Company’s first-in-class VEGF-C/D “trap” inhibitor will be highlighted during the upcoming American Society of Retina Specialists 2023 Annual Meeting in Seattle, Washington.

  July 13, 2023

   · 

  4 min read
• Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

  Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023.

  July 13, 2023

   · 

  3 min read
• BioMidwest

  SoftWave TRT Leads the Charge: Secures CPT Code Approval for Groundbreaking men’s sexual health and Shockwave Therapy

  SoftWave Tissue Regeneration Technologies, the leading innovator in the field of shockwave technology, is pleased to announce a significant milestone that will revolutionize the treatments for men’s sexual health.

  July 13, 2023

   · 

  2 min read
• Business

  West to Host Second-Quarter 2023 Conference Call

  West Pharmaceutical Services, Inc. announced that it will release second-quarter 2023 financial results before the market opens on Thursday, July 27, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

  July 13, 2023

   · 

  2 min read
• BioForest

  Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries

  Partnership Aims to Accelerate the Development of Dispersible Pediatric HIV Medicines Gilead Sciences, Inc. is pleased to announce two public-private partnerships.

  July 13, 2023

   · 

  6 min read
• Deals

  Labcorp Declares Quarterly Dividend - July 13, 2023

  Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.

  July 13, 2023

   · 

  1 min read
• Genetown

  TheracosBio Announces Commercial Availability of Brenzavvy™ (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes

  TheracosBio announced that Brenzavvy™, an FDA-approved oral sodium-glucose cotransporter 2 inhibitor, is now available by prescription through the Mark Cuban Cost Plus Drug Company, PBC.

  July 13, 2023

   · 

  10 min read
• Biotech Bay

  Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference

  Nevro Corp. today announced that 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT).

  July 13, 2023

   · 

  3 min read